Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

por García-Campelo, Rosario, Sullivan, Ivana, Arriola, Edurne, Insa, Amelia, Juan Vidal, Oscar, Cruz-Castellanos, Patricia, Morán, Teresa, Reguart, Noemí, Zugazagoitia, Jon, Dómine, Manuel
Publicado 2023

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

por García-Campelo, Rosario, Sullivan, Ivana, Arriola, Edurne, Insa, Amelia, Juan Vidal, Oscar, Cruz-Castellanos, Patricia, Morán, Teresa, Reguart, Noemí, Zugazagoitia, Jon, Dómine, Manuel
Publicado 2023

Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Res...

por Alen, Begoña O., Estévez-Pérez, Lara S., Hermida-Romero, María Teresa, Reguera-Arias, Ana, García-Campelo, Rosario, de la Torre-Bravos, Mercedes, Concha, Ángel
Publicado 2022

Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blo...

por Riudavets, Mariona, Mosquera, Joaquin, Garcia-Campelo, Rosario, Serra, Jorgina, Anguera, Georgia, Gallardo, Pablo, Sullivan, Ivana, Barba, Andrés, del Carpio, Luís, Barnadas, Agustí, Gich, Ignasi, Majem, Margarita
Publicado 2020

BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib

por Karachaliou, Niki, Arrieta, Oscar, Giménez-Capitán, Ana, Aldeguer, Erika, Drozdowskyj, Ana, Chaib, Imane, Reguart, Noemí, Garcia-Campelo, Rosario, Chen, Jing-Hua, Molina-Vila, Miguel Angel, Rosell, Rafael
Publicado 2020

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study

por Viñolas, N. Nuria, Garcia-Campelo, Rosario, Majem, Margarita, Carcereny, Enric, Isla, Dolores, Gonzalez-Larriba, José Luis, Coves, Juan, De-Castro, Javier, Domine, Manuel, Lianes, Piar, Artal, Angel, Remon, Jordi, Felip, Enriqueta, Garrido, Pilar
Publicado 2020

SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021)

por Martínez-García, María, Servitja Tormo, Sonia, Vilariño Quintela, Noelia, Arance Fernández, Ana, Berrocal Jaime, Alfonso, Cantos Sánchez de Ibargüen, Blanca, Del Barco Berrón, Sonia, García Campelo, Rosario, Gironés Sarrió, Regina, Manuel Sepúlveda-Sánchez, Juan
Publicado 2022

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program

por Bernabé-Caro, Reyes, Garrido, Pilar, García-Campelo, Rosario, Palmero, Ramón, Artal, Ángel, Bayona, Cristina, Rodríguez-Abreu, Delvys, López-Brea, Marta, Paredes, Alfredo, Vicente, David, Sánchez Torres, José Miguel, Majem, Margarita, Diz, Pilar, Gordo, Rocío, Coca, Margarita, de Castro, Javier
Publicado 2022

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

por Simonetti, Sara, Molina, Miguel Angel, Queralt, Cristina, de Aguirre, Itziar, Mayo, Clara, Bertran-Alamillo, Jordi, Sanchez, José Javier, Gonzalez-Larriba, Jose Luis, Jimenez, Ulpiano, Isla, Dolores, Moran, Teresa, Viteri, Santiago, Camps, Carlos, Garcia-Campelo, Rosario, Massuti, Bartomeu, Benlloch, Susana, y Cajal, Santiago Ramon, Taron, Miquel, Rosell, Rafael
Publicado 2010

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

por Sánchez‐Herrero, Estela, Serna‐Blasco, Roberto, Ivanchuk, Vadym, García‐Campelo, Rosario, Dómine Gómez, Manuel, Sánchez, José M., Massutí, Bartomeu, Reguart, Noemi, Camps, Carlos, Sanz‐Moreno, Sandra, Calabuig‐Fariñas, Silvia, Jantus‐Lewintre, Eloísa, Arnal, Magdalena, Fernández‐Orth, Dietmar, Calvo, Virginia, González‐Rumayor, Víctor, Provencio, Mariano, Romero, Atocha
Publicado 2021

Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry

por Franco, Fernando, Carcereny, Enric, Guirado, Maria, Ortega, Ana L., López-Castro, Rafael, Rodríguez-Abreu, Delvys, García-Campelo, Rosario, del Barco, Edel, Juan, Oscar, Aparisi, Francisco, González-Larriba, Jose L., Domine, Manuel, Trigo, Jose M., Cobo, Manuel, Cerezo, Sara, Calzas, Julia, Massutí, Bartomeu, Bosch-Barrera, Joaquim, García Coves, Paola, Domènech, Marta, Provencio, Mariano
Publicado 2021

Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemis...

por Conde, Esther, Suárez-Gauthier, Ana, Benito, Amparo, Garrido, Pilar, García-Campelo, Rosario, Biscuola, Michele, Paz-Ares, Luis, Hardisson, David, de Castro, Javier, Camacho, M. Carmen, Rodriguez-Abreu, Delvys, Abdulkader, Ihab, Ramirez, Josep, Reguart, Noemí, Salido, Marta, Pijuán, Lara, Arriola, Edurne, Sanz, Julián, Folgueras, Victoria, Villanueva, Noemí, Gómez-Román, Javier, Hidalgo, Manuel, López-Ríos, Fernando
Publicado 2014

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)

por Sánchez-Ares, María, Cameselle-Teijeiro, José M., Vázquez-Estévez, Sergio, Lázaro-Quintela, Martín, Vázquez-Boquete, Ángel, Afonso-Afonso, Francisco J., Casal-Rubio, Joaquín, González-Piñeiro, Ana L., Rico-Rodríguez, Yolanda, Fírvida-Pérez, José L., Ruíz-Bañobre, Juan, Couso, Elena, Santomé, Lucía, Pérez-Becerra, Raquel, García-Campelo, Rosario, Amenedo, Margarita, Azpitarte-Raposeiras, Cristina, Antúnez, José, Abdulkader, Ihab
Publicado 2016

Lung cancer symptoms at diagnosis: results of a nationwide registry study

por Ruano-Raviña, Alberto, Provencio, Mariano, Calvo de Juan, Virginia, Carcereny, Enric, Moran, Teresa, Rodriguez-Abreu, Delvys, López-Castro, Rafael, Cuadrado Albite, Eugenio, Guirado, María, Gómez González, Lucía, Massutí, Bartomeu, Ortega Granados, Ana Laura, Blasco, Ana, Cobo, Manuel, Garcia-Campelo, Rosario, Bosch, Joaquim, Trigo, José, Juan, Óscar, Aguado de la Rosa, Carlos, Dómine, Manuel, Sala, María, Oramas, Juana, Casal-Rubio, Joaquín, Cerezo, Sara
Publicado 2020

Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

por Cascone, Tina, Kar, Gozde, Spicer, Jonathan D., García-Campelo, Rosario, Weder, Walter, Daniel, Davey B., Spigel, David R., Hussein, Maen, Mazieres, Julien, Oliveira, Julio, Yau, Edwin H., Spira, Alexander I., Anagnostou, Valsamo, Mager, Raymond, Hamid, Oday, Cheng, Lin-Yang, Zheng, Ying, Blando, Jorge, Tan, Tze Heng, Surace, Michael, Rodriguez-Canales, Jaime, Gopalakrishnan, Vancheswaran, Sellman, Bret R., Grenga, Italia, Soo-Hoo, Yee, Kumar, Rakesh, McGrath, Lara, Forde, Patrick M.
Publicado 2023

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data

por Gutiérrez, Lourdes, Royuela, Ana, Carcereny, Enric, López-Castro, Rafael, Rodríguez-Abreu, Delvys, Massuti, Bartomeu, González-Larriba, José Luis, García-Campelo, Rosario, Bosch-Barrera, Joaquim, Guirado, María, Camps, Carlos, Dómine, Manuel, Bernabé, Reyes, Casal, Joaquín, Oramas, Juana, Ortega, Ana Laura, Sala, Mª. Angeles, Padilla, Airam, Aguiar, David, Juan-Vidal, Oscar, Blanco, Remei, del Barco, Edel, Martínez-Banaclocha, Natividad, Benítez, Gretel, de Vega, Blanca, Hernández, Ainhoa, Saigi, Maria, Franco, Fernando, Provencio, Mariano
Publicado 2021

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

por Provencio, Mariano, Cobo, Manuel, Rodriguez-Abreu, Delvys, Calvo, Virginia, Carcereny, Enric, Cantero, Alexandra, Bernabé, Reyes, Benitez, Gretel, Castro, Rafael López, Massutí, Bartomeu, del Barco, Edel, García Campelo, Rosario, Guirado, Maria, Camps, Carlos, Ortega, Ana Laura, González Larriba, Jose Luis, Sánchez, Alfredo, Casal, Joaquín, Sala, M. Angeles, Juan-Vidal, Oscar, Bosch-Barrera, Joaquim, Oramas, Juana, Dómine, Manuel, Trigo, Jose Manuel, Blanco, Remei, Calzas, Julia, Morilla, Idoia, Padilla, Airam, Pimentao, Joao, Sousa, Pedro A., Torrente, Maria
Publicado 2022

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry

por Mountzios, Giannis, Planchard, David, Metro, Giulio, Tsiouda, Dora, Prelaj, Arsela, Lampaki, Sofia, Shalata, Walid, Riudavets, Mariona, Christopoulos, Petros, Girard, Nicolas, Albarrán-Artahona, Víctor, Garcia Campelo, Rosario, Samitas, Konstantinos, Banna, Giuseppe Luigi, Boukovinas, Ioannis, Agbarya, Abed, Koumarianou, Anna, Perdikouri, Eleni-Isidora, Kosmidis, Paris, Linardou, Helena, Mauri, David, Mavroudis, Dimitrios, Athanasiadis, Ilias, Kalofonos, Haralambos, Xenidis, Nikolaos, Korantzis, Ippokratis, Ardavanis, Alexandros, Rallis, Grigorios, Bottiglieri, Achille, Efthymiadis, Konstantinos, Oikonomopoulos, Georgios, Kokkalis, Alexandros, Saloustros, Emmanouil, Tsoukalas, Nikolaos, Bartzi, Dimitra, Economopoulou, Panagiota, Psyrri, Amanda, Reck, Martin, Lo Russo, Giuseppe
Publicado 2022

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

por Karachaliou, Niki, Codony-Servat, Jordi, Teixidó, Cristina, Pilotto, Sara, Drozdowskyj, Ana, Codony-Servat, Carles, Giménez-Capitán, Ana, Molina-Vila, Miguel Angel, Bertrán-Alamillo, Jordi, Gervais, Radj, Massuti, Bartomeu, Morán, Teresa, Majem, Margarita, Felip, Enriqueta, Carcereny, Enric, García-Campelo, Rosario, Viteri, Santiago, González-Cao, María, Morales-Espinosa, Daniela, Verlicchi, Alberto, Crisetti, Elisabetta, Chaib, Imane, Santarpia, Mariacarmela, Luis Ramírez, José, Bosch-Barrera, Joaquim, Felipe Cardona, Andrés, de Marinis, Filippo, López-Vivanco, Guillermo, Miguel Sánchez, José, Vergnenegre, Alain, Sánchez Hernández, José Javier, Sperduti, Isabella, Bria, Emilio, Rosell, Rafael
Publicado 2015

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

por Karachaliou, Niki, Codony-Servat, Jordi, Teixidó, Cristina, Pilotto, Sara, Drozdowskyj, Ana, Codony-Servat, Carles, Giménez-Capitán, Ana, Molina-Vila, Miguel Angel, Bertrán-Alamillo, Jordi, Gervais, Radj, Massuti, Bartomeu, Morán, Teresa, Majem, Margarita, Felip, Enriqueta, Carcereny, Enric, García-Campelo, Rosario, Viteri, Santiago, González-Cao, María, Morales-Espinosa, Daniela, Verlicchi, Alberto, Crisetti, Elisabetta, Chaib, Imane, Santarpia, Mariacarmela, Luis Ramírez, José, Bosch-Barrera, Joaquim, Felipe Cardona, Andrés, de Marinis, Filippo, López-Vivanco, Guillermo, Miguel Sánchez, José, Vergnenegre, Alain, Sánchez Hernández, José Javier, Sperduti, Isabella, Bria, Emilio, Rosell, Rafael
Publicado 2023